If you are reading this message in plaintext or if you have an AOL address you must click on this link: http://listserv.otcjournal.com/otcjournal/20020128-1.html  and wait for a web page to automatically open up to properly read this newsletter. 
[IMAGE]		[IMAGE][IMAGE]	


[IMAGE]	


  [IMAGE] January 28, 2002 [IMAGE]   [IMAGE] Volume V, Issue 8 [IMAGE]     Email : info@otcjournal.com   URL : http://www.otcjournal.com    To OTC Journal Members:      [IMAGE] Special Announcement- Update on Next Profile- Expected To Trade Between February 5th and 8th   We are very excited about our next profile, which will probably be coming next week. We can't say exactly when because the company will be going public through an RTO, and it will open for trading on the American Stock Exchange at a yet to be determined time. Sometime during the week beginning February 4th is the anticipated opening. It could open at any time during the week. To learn more about RTOs, you can read our January 16th  edition, which describes in detail how they work.   The company is a medical device manufacturer already generating significant sales. The company expects to turn cash flow positive this year, and last week attained its second FDA Approval, lending itself to even more preliminary interest in the stock. This company fits perfectly with the Bio-Tech revolution, a group we believe will generate prolific profits for investors who choose the right stocks during the first decade of the 21st century. Please read our January 19th  edition for our views on this matter.   One of this company's therapies has already been featured on a special segment on Good Morning America, and their shareholders' list reads like of Who's Who of major Wall Street names and International Financiers.   Because this company will not be going public through the traditional IPO, all open market investors will be on an equal playing field once the stock begins trading.   When the stock opens for trading the OTC Journal will immediately send out our profile on the company. You will be provided with all the facts and figures you need to make an informed investment decision, but you should still make an effort to confirm all information through independent third party sources, i.e. the SEC Edgar filings and the company's web site.   We have come up with a solution to get you the profile as soon as the stock opens for trading. Simply visit our Home Page  frequently at www.otcjournal.com  starting next week. At the top of our home page you will find a notice informing you whether the stock has opened for trading. Once the stock opens, our banner will be give you the name, symbol, and current quote. After trading begins you will be able to simply click on the banner, and the full profile on the company will open up automatically. More information in this weekend's edition.   There is already a tremendous "buzz" on this company in the small cap community, and we believe the stock could trade like a hot IPO. Start checking our home page at www.otcjournal.com  one week from Friday morning if you want the advantage of getting in on the ground floor.     [IMAGE] Cross Media Marketing (AMEX: XMM)- News After the Close [IMAGE]  [IMAGE]  Cross Media issued a news release after the close today. The company disclosed a new product launch- Destinations Direct (http://www.destinations-direct.com ), an international discount  travel club. This new product has been in development stage for over six months.   The company will now "Cross Market" this new product through its current channels of distribution which include their 30 million plus consumer database, the 20 million member database at Lifeminders, and the 62 million households who receive Parade Magazine with their Sunday newspaper.   More importantly, the company reiterated its 2002 projections of $200 million in sales and earnings in excess of $1.25 per share.   The market is placing a mean PE Ratio of 17.5 x 2002 earnings on the Direct Marketing Services Group. Therefore, if Cross Media can simply trade up to the average of the group, the stock could attain a level of about $22 per share (17.5 x $1.25 in earnings).   Shares of Cross Media have enjoyed significant institutional accumulation since the company completed a successful 1 for 5 reverse split at the end of October. The company is now starting to garner more institutional interest, and it is only a matter of time before a major Wall Street firm jumps on the Cross Media band wagon.   We believe the recent weakness in the share price in sympathy to the pullback in the NASDAQ is a buying opportunity. Regardless of the speed of the economic recovery, the market will still pay for solid earnings.  $20 is our price target for 2002, up from the $15 price target we had when prior to the acquisition of National Syndications, the publisher of Parade Magazine.   Charts Provided Courtesy Of TradePortal.com    The OTC Journal is a proud partner of the SwingWire.com Online Investment Community . A next generation Online Analyst Exchange providing Members the ability to search, review, track and monitor some of the Internet's best Online CAs (CyberAnalysts). Members have the opportunity to potentially achieve higher returns by viewing top performing portfolios and receiving real-time alerts from favorite CAs.    SwingWire.com  also has a lucrative incentive model for experienced investors and traders who consistently outperform the market. Share market ideas with other like-minded investors, establish a proven track record, provide insightful commentary, attract followers and ultimately become one of the Internet's highest paid and most sought after CyberAnalysts!    Click here to receive your FREE 30-Day Trial Membership with no further obligation. Sign Up Today!        Disclaimer   The OTCjournal.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected  publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward  maximizing the upside potential for investors while minimizing the downside risk, whenever possible.  Moreover, as detailed below, this publication accepts compensation from certain of the companies which it features.  Likewise, this newsletter is owned by MarketByte, LLC.  To the degrees enumerated herein,  this newsletter should not be regarded as an independent publication.   Click Here  to view our compensation on every company we have ever covered, or visit the following web address:  http://www.otcjournal.com/disclaimer.html  for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html  for Trading Alerts.   All statements and expressions are the sole  opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities  mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.   The editor, members of the editor's family, and/or entities with which they are affiliated, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.   The profiles, critiques, and other editorial content of the OTCjournal.com may contain forward-looking statements relating to the expected capabilities of the companies mentioned herein.   THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN  SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN  CONSENT OF THE EDITORS OF OTCjournal.com.   We encourage our readers to invest carefully and read the investor information available at the web sites of  the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com . We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at  http://www.sec.gov/consumer/cyberfr.htm . Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.     Unsubscribe Here     You can unsubscribe from this list at any time by Clicking Here  and HITTING SEND. If you are having difficulty removing yourself or wish to change your address please go to http://listserv.otcjournal.com/opt.cgi?email=andrew.h.lewis@enron.com .   	


[IMAGE]		
[IMAGE]		
[IMAGE]		
[IMAGE]		
[IMAGE]		
[IMAGE]		
[IMAGE]		
[IMAGE]		
[IMAGE]	[IMAGE]	

  
  ---
You are currently subscribed to otcjournal as: andrew.h.lewis@enron.com
To unsubscribe send a blank email to leave-otcjournal-3119263F@lyris.otcjournal.com